Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses

被引:478
作者
Chi, HB
Barry, SP
Roth, RJ
Wu, JJ
Jones, EA
Bennettt, AM
Flavell, RA
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA
[4] UCL, Inst Child Hlth, Med Mol Biol Unit, London WC1N 1EH, England
关键词
IL-10; innate immunity; phosphatase; toll-like receptor signaling; TNF-alpha;
D O I
10.1073/pnas.0510965103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Engagement of Toll-like receptors (TLRs) on macrophages leads to activation of the mitogen-activated protein kinases (MAPKs), which contribute to innate immune responses. MAPK activity is regulated negatively by MAPK phosphatases (MKPs). MKR-1, the founding member of this family of dual-specificity phosphatases, has been implicated in regulating lipopolysaccharide (LPS) responses, but its role in TLR-mediated immune responses in vivo has not been defined. Here, we show that mice deficient in MKP-1 were highly susceptible to endotoxic shock in vivo, associated with enhanced production of proinflammatory cytokines TNF-alpha and IL-6 and an anti-inflammatory cytokine, IL-10. We further examined the regulation and function of MKP-1 in macrophages, a major cell type involved in endotoxic shock. MKP-1 was transiently induced by TLR stimulation through pathways mediated by both myeloid differentiation factor 88 (MyD88) and TIR domain-containing adaptor inducing IFN-beta (TRIF). MKP-1 deficiency led to sustained activation of p38 MAPK and c-Jun N-terminal kinase (JNK) in LPS-treated macrophages. In response to TLR signals, MKP-1-deficient macrophages produced 5- to 10-fold higher IL-10, which could be blocked by a p38 MAPK inhibitor. Thus, p38 MAPK plays a critical role in mediating IL-10 synthesis in TLR signaling. TNF-a was found to be more abundant in MKP-1-deficient macrophages within 2 hours of TLR stimulation, but its production was rapidly down-regulated by IL-10. Our studies demonstrate that MKP-1 attenuates the activities of p38 MAPK and JNK to regulate both pro- and anti-inflammatory cytokines in TLR signaling. These results highlight the complex mechanisms by which the MAPKs regulate innate immunity.
引用
收藏
页码:2274 / 2279
页数:6
相关论文
共 31 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[3]   Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation [J].
Brondello, JM ;
Pouysségur, J ;
McKenzie, FR .
SCIENCE, 1999, 286 (5449) :2514-2517
[4]   Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages [J].
Chen, PL ;
Li, J ;
Barnes, J ;
Kokkonen, GC ;
Lee, JC ;
Liu, YS .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6408-6416
[5]   GADD45β/GADD45γ and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNγ production in T cells [J].
Chi, HB ;
Lu, BF ;
Takekawa, M ;
Davis, RJ ;
Flavell, RA .
EMBO JOURNAL, 2004, 23 (07) :1576-1586
[6]   MAP kinases in the immune response [J].
Dong, C ;
Davis, RJ ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :55-72
[7]  
Dorfman K, 1996, ONCOGENE, V13, P925
[8]   Structure and regulation of MAPK phosphatases [J].
Farooq, A ;
Zhou, MM .
CELLULAR SIGNALLING, 2004, 16 (07) :769-779
[9]   Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells [J].
Franklin, CC ;
Kraft, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :16917-16923
[10]   INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].
GERARD, C ;
BRUYNS, C ;
MARCHANT, A ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
DELVAUX, A ;
FIERS, W ;
GOLDMAN, M ;
VELU, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550